Protocol of an open-label safety and feasibility pilot study of ketamine-assisted psychotherapy for methamphetamine use disorder (the KAPPA trial)
Introduction Methamphetamine use disorder is a significant public health concern. No pharmacological treatment options currently exist for methamphetamine use disorder, and psychotherapy is only moderately effective. Preliminary evidence suggests that ketamine-assisted psychotherapy produces sustain...
Saved in:
Main Authors: | Jonathan Brett, Celia Morgan, Nadine Ezard, Brendan Clifford, Krista J Siefried, Robert May, Liam Acheson, Kathryn Fletcher, Harriet MacDonald, Gillinder Bedi, Alexandre Guerin, Elizabeth Knock, Michael Millard, Jess Doumany |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-02-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/15/2/e092504.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trial protocol of an open-label pilot study of oral naltrexone–bupropion combination pharmacotherapy for the treatment of methamphetamine use disorder (the NABU trial)
by: Jonathan Brett, et al.
Published: (2025-02-01) -
PSYCHOTHERAPY
by: Ileana-Pepita Stoica
Published: (2021-04-01) -
The theory and practice of group psychotherapy /
by: Yalom, Irvin D., 1931-
Published: (1985) -
Case report of glomerular histiocytosis associated with non-crystalline IgG-kappa paraproteinemia
by: Aditya Kishore, et al.
Published: (2025-02-01) -
Methamphetamine Use: A Narrative Review of Adverse Effects and Related Toxicities
by: Amber N. Edinoff, et al.
Published: (2022-09-01)